Halting the Epidemic of Addiction and Loss Act of 2025

Summary

Halting the Epidemic of Addiction and Loss Act of 2025 This bill requires that, when the Department of Health and Human Services (HHS) issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the Food and Drug Administration. Within one year after the bill’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the bill’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Assigned to a committee for review.

Senate Committee on Health, Education, Labor, and Pensions · U.S. Senate

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Cosponsors

Related bills

• H.R. 2483SUPPORT for Patients and Communities Reauthorization Act of 2025Related bill, contained in public law

As identified by Congress.gov.

Full history

1. Jul 17, 2025

   Introduced

   Introduced in U.S. Senate

   U.S. Senate

2. Jul 17, 2025

   Referred to committee

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

3. Jul 17, 2025

   Referred to committee

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Read the record

• Read on Congress.gov (opens in a new tab) The official record on Congress.gov.